These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10606392)

  • 1. Effect of gamma-hydroxybutyrate on pain, fatigue, and alpha sleep anomaly in patients with fibromyalgia.
    Russell AS
    J Rheumatol; 1999 Dec; 26(12):2712. PubMed ID: 10606392
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of gamma-hydroxybutyrate on pain, fatigue, and the alpha sleep anomaly in patients with fibromyalgia. Preliminary report.
    Scharf MB; Hauck M; Stover R; McDannold M; Berkowitz D
    J Rheumatol; 1998 Oct; 25(10):1986-90. PubMed ID: 9779855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia.
    Scharf MB; Baumann M; Berkowitz DV
    J Rheumatol; 2003 May; 30(5):1070-4. PubMed ID: 12734908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial.
    Russell IJ; Perkins AT; Michalek JE;
    Arthritis Rheum; 2009 Jan; 60(1):299-309. PubMed ID: 19116896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of the narcoleptiform sleep disorder in chronic fatigue syndrome and fibromyalgia with sodium oxybate.
    Spitzer AR; Broadman M
    Pain Pract; 2010; 10(1):54-9. PubMed ID: 20629967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: results from a 14-week, randomized, double-blind, placebo-controlled study.
    Russell JI; Holman AJ; Swick TJ; Alvarez-Horine S; Wang GY; Guinta D;
    Pain; 2011 May; 152(5):1007-1017. PubMed ID: 21397402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium oxybate for the treatment of fibromyalgia.
    Staud R
    Expert Opin Pharmacother; 2011 Aug; 12(11):1789-98. PubMed ID: 21679091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trial.
    Spaeth M; Bennett RM; Benson BA; Wang YG; Lai C; Choy EH
    Ann Rheum Dis; 2012 Jun; 71(6):935-42. PubMed ID: 22294641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sodium oxybate on sleep physiology and sleep/wake-related symptoms in patients with fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study.
    Moldofsky H; Inhaber NH; Guinta DR; Alvarez-Horine SB
    J Rheumatol; 2010 Oct; 37(10):2156-66. PubMed ID: 20682669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of fibromyalgia with cyclobenzaprine: A meta-analysis.
    Tofferi JK; Jackson JL; O'Malley PG
    Arthritis Rheum; 2004 Feb; 51(1):9-13. PubMed ID: 14872449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep related myoclonus in rheumatic pain modulation disorder (fibrositis syndrome).
    Moldofsky H; Tullis C; Lue FA
    J Rheumatol; 1986 Jun; 13(3):614-7. PubMed ID: 3461158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Questioning the likelihood that sodium oxybate can be used to successfully treat fibromyalgia: comment on the article by Russell et al.
    Alarcón GS
    Arthritis Rheum; 2009 Sep; 60(9):2854. PubMed ID: 19714625
    [No Abstract]   [Full Text] [Related]  

  • 13. Sodium oxybate: not authorised for fibromyalgia.
    Prescrire Int; 2012 Dec; 21(133):290. PubMed ID: 23373093
    [No Abstract]   [Full Text] [Related]  

  • 14. Increase in sleep-related breathing disturbances after treatment with sodium oxybate in patients with narcolepsy and mild obstructive sleep apnea syndrome: two case reports.
    Seeck-Hirschner M; Baier PC; von Freier A; Aldenhoff J; Göder R
    Sleep Med; 2009 Jan; 10(1):154-5. PubMed ID: 18226949
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to Editorial: "Xyrem safety: The debate continues".
    Zvosec DL; Smith SW
    Sleep Med; 2010 Jan; 11(1):108; author reply 108-9. PubMed ID: 19959395
    [No Abstract]   [Full Text] [Related]  

  • 16. Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study.
    Ondo WG; Perkins T; Swick T; Hull KL; Jimenez JE; Garris TS; Pardi D
    Arch Neurol; 2008 Oct; 65(10):1337-40. PubMed ID: 18852348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pain and arthritis.
    Winfield JB
    N C Med J; 2007; 68(6):444-6. PubMed ID: 18236866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
    Black J; Pardi D; Hornfeldt CS; Inhaber N
    Sleep Med; 2009 Sep; 10(8):829-35. PubMed ID: 19616998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic treatment of fibromyalgia.
    Baker K; Barkhuizen A
    Curr Pain Headache Rep; 2005 Oct; 9(5):301-6. PubMed ID: 16157056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.
    Holman AJ; Myers RR
    Arthritis Rheum; 2005 Aug; 52(8):2495-505. PubMed ID: 16052595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.